drugset / Trial / NCT00624715
Cannabinoid Receptor Function & Alcoholism
Phase 1
Completed
29 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedCrossoverQuadruple-blindBasic science
Summary
This study attempts to characterize the effects of tetrahydrocannabinol (THC). Tetrahydrocannabinol is the active ingredient of marijuana, cannabis, "ganja", or "pot". This study will involve healthy volunteers who 1) have no history of alcoholism in their family or 2) have a family history of alcoholism. This study looks at individuals with or without a family history of alcoholism to determine if there is a difference between the two groups in the response to THC.
Timeline
- Start
- 2007-08-09
- Primary completion
- 2010-06-22
- Completion
- 2010-06-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dronabinol | Other / unclassified | 0.0036 mg/kg | Intravenous |
| Comparator | Dronabinol | Other / unclassified | 0.018 mg/kg | Intravenous |
| Comparator | Dronabinol | Other / unclassified | 0.036 mg/kg | Intravenous |